Mangoceuticals Shares Are Trading Higher After the Company Announced the Development of Proprietary Formulations of Enclomiphene Citrate, Pregnenolone and Dehydroepiandrosterone in an Oral Dissolvable Tablet for the Treatment of Low Testosterone and Male
Mangoceuticals Shares Are Trading Higher After the Company Announced the Development of Proprietary Formulations of Enclomiphene Citrate, Pregnenolone and Dehydroepiandrosterone in an Oral Dissolvable Tablet for the Treatment of Low Testosterone and Male
Mangoceuticals 公司宣佈開發出枸櫞酸恩克洛米芬、孕烯醇酮和脫氫表雄酮口服可溶片劑專有配方，用於治療低睾酮症和男性勃起功能障礙，公司股價隨之走高
Mangoceuticals 公司宣佈開發出枸櫞酸恩克洛米芬、孕烯醇酮和脫氫表雄酮口服可溶片劑專有配方，用於治療低睾酮症和男性勃起功能障礙，公司股價隨之走高。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。